These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11964110)

  • 1. The Benzodiazepine Withdrawal Symptom Questionnaire: psychometric evaluation during a discontinuation program in depressed chronic benzodiazepine users in general practice.
    Couvée JE; Zitman FG
    Addiction; 2002 Mar; 97(3):337-45. PubMed ID: 11964110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-validation, predictive validity, and time course of the Benzodiazepine Dependence Self-Report Questionnaire in a benzodiazepine discontinuation trial.
    Oude Voshaar RC; Mol AJ; Gorgels WJ; Breteler MH; van Balkom AJ; van de Lisdonk EH; Kan CC; Zitman FG
    Compr Psychiatry; 2003; 44(3):247-55. PubMed ID: 12764713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C; Chabannes JP; Saviuc P
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term benzodiazepine users 3 years after participation in a discontinuation program.
    Rickels K; Case WG; Schweizer E; Garcia-Espana F; Fridman R
    Am J Psychiatry; 1991 Jun; 148(6):757-61. PubMed ID: 2035717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absence of benzodiazepine craving in a general practice benzodiazepine discontinuation trial.
    Mol AJ; Oude Voshaar RC; Gorgels WJ; Breteler MH; van Balkom AJ; van de Lisdonk EH; Kan CC; Mulder J; Zitman FG
    Addict Behav; 2006 Feb; 31(2):211-22. PubMed ID: 15951127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Benzodiazepine Withdrawal Symptom Questionnaire.
    Tyrer P; Murphy S; Riley P
    J Affect Disord; 1990 May; 19(1):53-61. PubMed ID: 1971833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dependence on benzodiazepine and treatment of withdrawal syndrome].
    Sep-Kowalikowa B; Czucha M
    Psychiatr Pol; 2002; 36(6 Suppl):347-57. PubMed ID: 12647459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benzodiazepine dependence questionnaire: development, reliability and validity.
    Baillie AJ; Mattick RP
    Br J Psychiatry; 1996 Sep; 169(3):276-81. PubMed ID: 8879712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines.
    Bashir K; King M; Ashworth M
    Br J Gen Pract; 1994 Sep; 44(386):408-12. PubMed ID: 8790654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relevance of psychiatric and somatic comorbidity in depressed chronic benzodiazepine users.
    Couvée JE; Bakker A; Zitman FG
    Psychother Psychosom; 2002; 71(5):263-8. PubMed ID: 12207106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin for the discontinuation of long-term benzodiazepines use: an assessment of its effectiveness in daily clinical practice.
    Bobes J; Rubio G; Terán A; Cervera G; López-Gómez V; Vilardaga I; Pérez M
    Eur Psychiatry; 2012 May; 27(4):301-7. PubMed ID: 21334859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical scale to assess benzodiazepine withdrawal.
    Busto UE; Sykora K; Sellers EM
    J Clin Psychopharmacol; 1989 Dec; 9(6):412-6. PubMed ID: 2574193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal symptoms from high dose benzodiazepines in poly drug users.
    Seivewright N; Dougal W
    Drug Alcohol Depend; 1993 Mar; 32(1):15-23. PubMed ID: 8097996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia.
    Morin CM; Bastien C; Guay B; Radouco-Thomas M; Leblanc J; Vallières A
    Am J Psychiatry; 2004 Feb; 161(2):332-42. PubMed ID: 14754783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Depression and benzodiazepine dependence in the elderly. On the complexity of psychiatric manifestations and psychiatric treatment].
    Wolter-Henseler DK; Gadatsch MA; Schulte E
    Psychiatr Prax; 1994 Jul; 21(4):157-9. PubMed ID: 7938326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program.
    Voshaar RC; Gorgels WJ; Mol AJ; van Balkom AJ; Mulder J; van de Lisdonk EH; Breteler MH; Zitman FG
    Can J Psychiatry; 2006 Jun; 51(7):445-52. PubMed ID: 16838826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo].
    Hantouche EG; Guelfi JD; Comet D
    Encephale; 1998; 24(5):469-79. PubMed ID: 9850822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Benzodiazepine Dependence Questionnaire (BDEPQ): validity and reliability in Mexican psychiatric patients.
    Minaya O; Fresán A; Cortes-Lopez JL; Nanni R; Ugalde O
    Addict Behav; 2011 Aug; 36(8):874-7. PubMed ID: 21481543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protracted benzodiazepine withdrawal syndrome mimicking psychotic depression.
    Modell JG
    Psychosomatics; 1997; 38(2):160-1. PubMed ID: 9063050
    [No Abstract]   [Full Text] [Related]  

  • 20. Depression following withdrawal from long-term benzodiazepine use: a report of four cases.
    Olajide D; Lader M
    Psychol Med; 1984 Nov; 14(4):937-40. PubMed ID: 6152745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.